Tuesday, August 18, 2026
11:00am - 12:30pm EST
Online webinar
Selecting the correct developmental and reproductive toxicology (DART) study is essential for generating meaningful nonclinical safety data. Each study type captures a distinct developmental window, and choosing between EFD, FEED, PPND, and juvenile studies requires a clear understanding of the biological mechanisms and regulatory expectations that shape human health protection.
Join Inotiv’s Johnathan Furr and AtLee Watson as they outline how scientific rationale, developmental biology, and study design come together to ensure the right DART study is selected for your program. They will also highlight practical considerations for multigeneration studies such as OECD 421/422 and OECD 443—critical for chemicals, food products, and pharmaceuticals where exposure spans multiple reproductive and developmental stages.
Presented by Johnathan Furr and AtLee Watson
Tuesday, August 18 | 11 am–12:30 pm EDT
In this webinar, our scientists will discuss:
-
How to select the correct DART study based on developmental endpoints and regulatory objectives
-
Scientific differences between EFD, FEED, PPND, and juvenile study designs
-
How juvenile studies provide unique insight into pediatric risk
-
How appropriate study design strengthens nonclinical packages, avoids unnecessary animal use, and supports regulatory decision making
Don’t miss this opportunity to gain deeper scientific insight into how DART study selection shapes nonclinical strategy and reveals critical developmental mechanisms.
